{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-055936","form_type":"8-K","ticker":"RNTX","cik":"0001420565","company_name":"Rein Therapeutics, Inc.","filed_at":"2024-03-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.138412+00:00","generated_at":"2026-06-05T05:24:21.814217+00:00","sec_items":["5.02","8.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Dr. Nolan Sigal resigns from Aileron board; Nasdaq confirms compliance with annual meeting rule","bullets":["Dr. Nolan Sigal resigned from Board and Nominating Committee effective February 29, 2024; no disagreement cited.","Company received Nasdaq letter confirming regained compliance with Listing Rule 5620 (annual meeting requirement) on February 29, 2024.","No replacement director announced; Board size reduced."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-055936","json":"https://secwatch.observer/filing/0001193125-24-055936.json","markdown":"https://secwatch.observer/filing/0001193125-24-055936.md","text":"https://secwatch.observer/filing/0001193125-24-055936.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420565/000119312524055936/0001193125-24-055936-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420565/000119312524055936/d797289d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T05:24:21.814217+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3626c165be","claim":"Nolan Sigal resigned as member of the Board of Directors at Rein Therapeutics, Inc..","evidence_excerpt":"On February 29, 2024, Nolan Sigal, M.D., Ph.D., notified Aileron Therapeutics, Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company (the “Board”), effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1420565/000119312524055936/0001193125-24-055936-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"member of the Board of Directors"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}